Articulate Labs
TX - DallasBiotechnology
Focus: Articulate Labs is an early-stage biotechnology company focused on neurology and gastroenterology, currently developing KneeStim, a knee rehabilitation device for patellofemoral pain syndrome. Founded in 2023 and publicly traded, the company is in a pre-revenue to early commercialization phase.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Articulate Labs?
AI assessmentArticulate Labs suits risk-tolerant early-career professionals seeking founder-level impact in medical devices, but demands due diligence on clinical data, capital runway, and team before committing.
Why Work Here
- Ground-floor opportunity at a newly public company (2023) with minimal organizational hierarchy and potential for rapid career advancement
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
KneeStim
Patellofemoral Pain SyndromeClinical Trials (1)
NCT02243332Dynamic Quadriceps Muscle Stimulation for Treatment of Patellofemoral Pain
N/AHelp build intelligence for Articulate Labs
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.